Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 3.28 is 79% below its 5-year average of 15.91, near the low end of its 5-year range (3.28–96.85).
As of the fiscal period ended Tuesday, June 30, 2026. 40.52% below its 12-month average of 5.52.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 3.28.
QUICK RATIO (ACID-TEST)
3.28
QUICK RATIO (ACID-TEST) AVG TTM
5.52
QUICK RATIO (ACID-TEST) AVG 3Y
13.18
QUICK RATIO (ACID-TEST) AVG 5Y
15.91
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-40.52%
CURRENT VS 3Y AVG
-75.09%
CURRENT VS 5Y AVG
-79.36%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 870 covered companies
CURRENT VS SECTOR MEDIAN
-2.14%
vs the sector median at left
ARS Pharmaceuticals, Inc.
Market Cap
$426.51M
Quick Ratio (Acid-Test)
3.28
TTM Avg
5.52
3Y Avg
13.18
5Y Avg
15.91
Market Cap
$424.10M
Quick Ratio (Acid-Test)
3.35
TTM Avg
2.92
3Y Avg
4.56
5Y Avg
5.25
Market Cap
$422.86M
Quick Ratio (Acid-Test)
22.29
TTM Avg
19.64
3Y Avg
11.19
5Y Avg
11.30
Market Cap
$422.72M
Quick Ratio (Acid-Test)
1.37
TTM Avg
1.43
3Y Avg
1.40
5Y Avg
1.53
Market Cap
$431.97M
Quick Ratio (Acid-Test)
3.91
TTM Avg
4.41
3Y Avg
5.46
5Y Avg
6.71
Market Cap
$419.87M
Quick Ratio (Acid-Test)
25.05
TTM Avg
8.87
3Y Avg
10.83
5Y Avg
12.06
Market Cap
$418.95M
Quick Ratio (Acid-Test)
3.19
TTM Avg
3.65
3Y Avg
4.66
5Y Avg
6.11
Market Cap
$435.61M
Quick Ratio (Acid-Test)
3.46
TTM Avg
8.89
3Y Avg
4.63
5Y Avg
3.55
Market Cap
$416.27M
Quick Ratio (Acid-Test)
6.40
TTM Avg
3.40
3Y Avg
4.68
5Y Avg
4.62
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ARS Pharmaceuticals, Inc. (SPRY) | $426.51M | 3.28 | 5.52 | 13.18 | 15.91 |
| NeoGenomics, Inc. (NEO)vs › | $424.10M | 3.35 | 2.92 | 4.56 | 5.25 |
| Tectonic Therapeutic, Inc. (TECX)vs › | $422.86M | 22.29 | 19.64 | 11.19 | 11.30 |
| Tilray Brands, Inc. (TLRY)vs › | $422.72M | 1.37 | 1.43 | 1.40 | 1.53 |
| NeuroPace, Inc. (NPCE)vs › | $431.97M | 3.91 | 4.41 | 5.46 | 6.71 |
| Prothena Corporation plc (PRTA)vs › | $419.87M | 25.05 | 8.87 | 10.83 | 12.06 |
| Editas Medicine, Inc. (EDIT)vs › | $418.95M | 3.19 | 3.65 | 4.66 | 6.11 |
| YD Bio Limited Ordinary Shares (YDES)vs › | $435.61M | 3.46 | 8.89 | 4.63 | 3.55 |
| Senseonics Holdings, Inc. (SENS)vs › | $416.27M | 6.40 | 3.40 | 4.68 | 4.62 |
| Rezolute, Inc. (RZLT)vs › | $415.98M | 9.44 | 11.90 | 14.34 | 23.42 |
Quick Ratio
3.28
Excludes inventory
Current Ratio
3.48
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 3.28 |
| 2026-03-31 | 4.77 |
| 2025-12-31 | 7.06 |
| 2025-09-30 | 6.51 |
| 2025-06-30 | 5.98 |
| 2025-03-31 | 10.74 |
| 2024-12-31 | 14.04 |
| 2024-09-30 | 12.52 |
| 2024-06-30 | 32.82 |
| 2024-03-31 | 60.90 |
| 2023-12-31 | 96.85 |
| 2023-09-30 | 21.87 |
| 2023-06-30 | 25.37 |
| 2023-03-31 | 27.18 |
| 2022-12-31 | 51.01 |
| 2022-09-30 | 4.69 |
| 2022-06-30 | 6.08 |
| 2022-03-31 | 17.65 |
| 2021-12-31 | 7.42 |
| 2021-09-30 | 19.90 |
| 2021-06-30 | 23.35 |
| 2021-03-31 | 32.63 |
| 2020-12-31 | 40.69 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 0.59 |
